Astaxanthin attenuates the UVB-induced secretion of prostaglandin E2 and interleukin-8 in human keratinocytes by interrupting MSK1 phosphorylation in a ROS depletion-independent manner

Exp Dermatol. 2012 Jul:21 Suppl 1:11-7. doi: 10.1111/j.1600-0625.2012.01496.x.

Abstract

To elucidate the effects of redox balance regulation on cutaneous inflammation, we used the potent antioxidant astaxanthin (AX) to assess its effect on the UVB-induced secretion of PGE(2) and IL-8 in human keratinocytes and analysed its biological mechanism of action. The addition of AX (at 8 μm) to human keratinocytes even after UVB irradiation significantly down-regulated the increased secretion of PGE(2) or IL-8. Those suppressive effects were accompanied by significantly decreased expression of genes encoding COX-2 or IL-8 as well as COX-2 protein. Analysis using a specific NF-κB tanslocation inhibitor demonstrated that the UVB-stimulated secretion of PGE(2) and IL-8 was significantly abolished by its treatment prior to UVB irradiation. Western blotting of phosphorylated signalling molecules revealed that UVB irradiation (80 mJ/cm(2) ) significantly stimulated the phosphorylation of p38, ERK and JNK, which was not suppressed by treatment with AX after irradiation. In contrast, AX significantly inhibited the UVB-increased phosphorylation of mitogen- and stress-activated protein kinase (MSK)-1, NF-kBp65 or CREB even when treated postirradiation. Further, the MSK1 inhibitor H89 significantly down-regulated the increased secretion of PGE(2) and IL-8 in UVB-exposed human keratinocytes, following post-irradiation treatment. These findings suggests that AX attenuates the auto-phosphorylation of MSK1 required for its activation, which results in the decreased phosphorylation of NF-kBp65, which in turn probably leads to a deficiency of NF-kB DNA binding activity. This may be associated with the significant suppression of PGE(2) /IL-8 secretion via the down-regulated expression of COX-2 and IL-8 at the gene and/or protein levels.

MeSH terms

  • Cyclooxygenase 2 / metabolism
  • Dinoprostone / metabolism*
  • Down-Regulation
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Interleukin-8 / metabolism*
  • Isoquinolines / pharmacology
  • Keratinocytes / cytology*
  • Keratinocytes / drug effects
  • Keratinocytes / radiation effects
  • Microscopy, Confocal / methods
  • Models, Biological
  • Phosphorylation
  • Reactive Oxygen Species
  • Ribosomal Protein S6 Kinases, 90-kDa / metabolism*
  • Signal Transduction
  • Sulfonamides / pharmacology
  • Ultraviolet Rays
  • Xanthophylls / pharmacology

Substances

  • Enzyme Inhibitors
  • Interleukin-8
  • Isoquinolines
  • Reactive Oxygen Species
  • Sulfonamides
  • Xanthophylls
  • astaxanthine
  • Cyclooxygenase 2
  • Ribosomal Protein S6 Kinases, 90-kDa
  • mitogen and stress-activated protein kinase 1
  • Dinoprostone
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide